Atrial fibrillation trials in Mexico
2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStudy to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Where
- Aguascalientes, Chihuahua City, Culiacán, Guadalajara, Guerrero, Mexico City, Monterrey, Querétaro, San Luis Potosí City, Tlalpan, Veracruz, Xalapa
- Age
- 65 years and over
- People
- 2,500 worldwide
- Run by
- Anthos Therapeutics, Inc.
See details and how to joinNCT05712200 · EU 2023-503224-66-00 - No phaseNot yet taking people in MexicoCARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry
- Where
- Mexico City
- Age
- 18 years and over
- People
- 30
- Run by
- JULIO GRANADOS MONTIEL
See details and how to joinNCT07567378